Search
for
Sort by
Research 331–360 of 1000+
- Mechanisms of autophagy and their implications in dermatological disorders
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- Immune therapies for alopecia areata: evidence and new perspectives
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Global burden of alopecia areata from 1990 to 2019 and emerging treatment trends analyzed through GBD 2019 and bibliometric data
- What’s New in Hair Loss
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Biologics in the management of childhood atopic dermatitis
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report